Shortly after Kentucky announced its new work requirements for the Medicaid program, a lawsuit was brought by residents against the government. Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University, explains what other states looking to implement work requirements might face.
Shortly after Kentucky announced its new work requirements for the Medicaid program, a lawsuit was brought by residents against the government. Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University, explains what this lawsuit might mean for other states looking to implement work requirements.
Transcript
Kentucky residents have already brought a lawsuit against the government for the state’s Medicaid work requirement; do you expect this will be the result for most states that try to implement work requirements?
No, I don’t. I think that Kentucky represents a particularly severe version of work requirement. As I say, I expect that in Virginia it may be that this opens a door for us and that they will negotiate some combination of work supports as a part of a Medicaid expansion—while they may not be my first choice, are not supports that beneficiaries and potential beneficiaries don’t think they can live with.
Kentucky is quite unique because here’s a state that simply did an expansion and brought half million people into its program and the results have been what you would think in terms of care and access. There are clearly costs that the state has now because of the expansion that it didn’t have in the beginning but that’s a different set of problems from just deciding you’re going to A) remove 1000 people and B) you’re going to make the program so hard to get into that people won’t enroll.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More